Moral Hazard

Overview

Moral hazard occurs when protection from the consequences of an action changes a person’s behaviour because some resulting costs or risks are borne by another party.

In health economics, the concept most commonly describes behavioural responses to insurance. When insurance reduces the price a patient pays for healthcare, the patient may use more care than they would if they faced the full cost. Moral hazard can also affect prevention, treatment choices, provider behaviour and decisions made by organisations protected from financial loss.

The term does not imply dishonesty or immoral conduct. It describes how incentives change when actions are imperfectly observable and their consequences are shared with someone else.

How Moral Hazard Arises

Moral hazard generally requires three conditions:

• one party is protected from at least part of a cost or risk;
• that party can take an action that affects the probability or size of the resulting cost; and
• the other party cannot perfectly observe, verify or contract over that action.

For example, health insurance transfers part of the financial cost of treatment from the patient to an insurer or public payer. Because the patient no longer faces the full price of care, insurance can change decisions about whether, when and how much healthcare to use.

This is an incentive effect rather than proof that an individual is deliberately exploiting the system. Behaviour can change simply because the price faced by the decision-maker has changed.

Ex Ante and Ex Post Moral Hazard

Moral hazard in health insurance is commonly divided into two forms.

Ex Ante Moral Hazard

Ex ante moral hazard occurs before illness or injury. Insurance may reduce the incentive to take preventive action because the insured person will not bear the full financial consequences of a future health event.

Possible examples include reduced investment in prevention, lower adherence to risk-reducing behaviour or greater participation in hazardous activities. Evidence of ex ante moral hazard varies considerably by behaviour and setting, and insurance can also increase prevention when preventive services are covered.

Ex Post Moral Hazard

Ex post moral hazard occurs after illness, injury or another insured event has occurred. Because insurance lowers the price paid at the point of use, the insured person may consume more healthcare than they would without coverage.

The additional use may include valuable treatment that was previously unaffordable as well as care whose expected benefit is small relative to its cost. Increased utilisation should therefore not automatically be classified as waste.

A Simple Economic Representation

Suppose a patient chooses healthcare quantity (q). Let (B(q)) represent the benefit obtained from care and (p) represent the resource cost of each unit.

Without insurance, the patient may face the full price (p) and choose care where:

[ MB(q)=p ]

where (MB(q)) is the marginal benefit of an additional unit of care.

If insurance requires the patient to pay only a proportion (c) of the price, where (0 \leq c < 1), the patient faces:

[ p_{\text{patient}}=cp ]

The patient then chooses care where:

[ MB(q)=cp ]

Because (cp<p), the insured quantity may be greater than the quantity selected at the full price. The difference represents the utilisation response to insurance. It does not establish that every additional service is unnecessary or socially inefficient.

Moral Hazard and the Value of Insurance

Insurance creates an important trade-off. It protects people against uncertain and potentially unaffordable costs, but it can also weaken the connection between healthcare use and the resource cost of providing that care.

Full insurance maximises financial protection but may produce stronger utilisation incentives. Greater cost sharing can reduce use but also exposes patients to more financial risk and may discourage high-value as well as low-value care.

The central policy problem is therefore not simply to eliminate moral hazard. It is to balance:

• protection against financial risk;
• access to beneficial healthcare;
• incentives for appropriate prevention and utilisation;
• administrative and monitoring costs; and
• the efficient use of limited healthcare resources.

Welfare Effects

A conventional analysis identifies a welfare loss when insurance causes consumption of care for which the patient’s marginal benefit is below the full social cost. This can occur because the patient responds to the out-of-pocket price rather than the total cost of treatment.

However, additional healthcare use after gaining insurance is not necessarily inefficient. Insurance can enable access to effective care that patients could not otherwise afford, improve health, reduce uncertainty and transfer resources to people when they are ill.

Assessing the welfare effect therefore requires more than measuring whether spending increased. Analysts must consider the health benefits of the additional care, financial protection, distributional consequences and any costs imposed on other members of the insurance pool or health system.

Demand-Side and Supply-Side Responses

Demand-side moral hazard concerns changes in patient behaviour, such as increased healthcare use when out-of-pocket prices fall.

Healthcare expenditure may also change through decisions made by clinicians or providers. A provider may influence the amount or type of care delivered when patients and payers cannot fully assess clinical necessity. This is more precisely examined through concepts such as provider-induced demand, agency problems and payment incentives rather than being attributed automatically to patient moral hazard.

Insurance arrangements may create interacting incentives for patients, providers and payers. A complete analysis should identify which party controls the relevant decision and who bears its consequences.

Managing Moral Hazard

Insurance and healthcare systems use several mechanisms to influence behaviour:

• deductibles, copayments and coinsurance;
• coverage limits and exclusions;
• prior authorisation and utilisation review;
• clinical guidelines and prescribing controls;
• provider payment methods;
• managed-care arrangements;
• incentives for prevention and adherence; and
• value-based insurance design.

These mechanisms involve trade-offs. Cost sharing may reduce unnecessary care, but it can also reduce effective treatment, worsen equity and impose financial hardship. Administrative controls may improve targeting but create delays, complexity and additional costs.

Value-based insurance design attempts to vary cost sharing according to the expected clinical value of care rather than applying the same charge to every service.

Evidence and Measurement

Moral hazard cannot be measured simply by comparing insured and uninsured people because their health risks and preferences may differ. This creates a selection problem.

Stronger empirical designs use randomised insurance arrangements, natural experiments, policy changes or credible quasi-experimental methods to isolate the effect of coverage or cost sharing on behaviour. Outcomes may include:

• healthcare utilisation;
• total and out-of-pocket spending;
• use of preventive services;
• treatment adherence;
• health outcomes;
• financial protection; and
• responses across different income or health-risk groups.

A rise in utilisation provides evidence of a behavioural response to insurance, but additional analysis is needed to determine whether the response improves or reduces welfare.

Relationship to Information Asymmetry

Moral hazard is associated with hidden action. It arises because one party cannot perfectly observe or control behaviour that occurs after protection or a contract is in place.

Adverse selection is associated with hidden information. It arises when individuals possess relevant information about their risk before contracting, affecting who purchases coverage or the terms on which exchange occurs.

Both can result from information asymmetry, but they describe different mechanisms and require different policy responses.

Applications Beyond Patient Insurance

The same incentive structure can occur outside individual health-insurance decisions. Examples include:

• providers protected from the financial consequences of inefficient practice;
• organisations expecting rescue when financial losses occur;
• manufacturers facing limited liability for certain risks;
• purchasers reimbursed by a separate budget holder; and
• institutions whose decisions impose costs on a wider system.

In each case, analysis should identify the protected party, the action that can change, the party bearing the resulting cost and the information preventing complete contracting.

Interpretation

Moral hazard is best understood as a consequence of incomplete contracts, imperfect observability and shared costs. It explains why protection against risk can change behaviour, but it does not establish that insurance is undesirable or that every behavioural response is inefficient.

The relevant health-economic question is whether an insurance or payment arrangement achieves an appropriate balance between financial protection, access, health outcomes, incentives and resource use.